← Browse by Condition
Medical Condition

motor neuron disease

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for motor neuron disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — motor neuron disease Clinical Trials

How many clinical trials are currently recruiting for motor neuron disease?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for motor neuron disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for motor neuron disease?
motor neuron disease research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a motor neuron disease clinical trial?
Eligibility criteria for motor neuron disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Haukeland University Hospital 1 trial
University of Ulster 1 trial
Synchron, Inc. 1 trial
Istituto Auxologico Italiano 1 trial

Recruiting Clinical Trials

NCT05744310
Recruiting
Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families
Enrollment
200 pts
Location
Norway
Sponsor
Haukeland University Hospital
View Trial →
NCT03827187
Recruiting
Awareness Detection and Communication in Disorders of Consciousness
Enrollment
30 pts
Location
Ireland, United King...
Sponsor
University of Ulster
View Trial →
NCT07533903
Recruiting
Functional Outcomes and Control Using Synchron BCI - Australia
Enrollment
10 pts
Location
Australia
Sponsor
Synchron, Inc.
View Trial →
NCT06318598
Recruiting
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
Enrollment
200 pts
Location
Italy
Sponsor
Istituto Auxologico Italiano
View Trial →

Related Conditions

amyotrophic lateral sclerosis (2) paralysis (2) nervous system diseases (1) spinal cord diseases (1) neurodegenerative diseases (1) tdp 43 proteinopathies (1) disorder of consciousness (1) stroke (1) physical disability (1) neurologic disorder (1) neurologic diseases (1) mnd motor neurone disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology